Navigation Links
2 Billion Dollar Tools Market for Cell and Gene Therapy, Says Report
Date:4/27/2021

The market for selected technologies and supplies commonly used in cell and gene therapy (CGT) research, development, clinical trial, and product manufacturing exceeded $2.1 billion in 2020. This was the finding made in Cell & Gene Therapy Technologies and Supplies, a market research report by Strategic Directions International, part of Science and Medicine Group.

SDi's report breaks the market into specific categories with defined markets. The market is led by cell expansion products, driven by costly GMP-grade consumables that are necessary for the culture of cells that are destined for infusion into humans. Currently, clinical trials account for a greater portion of cell expansion revenues than approved clinical use, but this dynamic will shift as an increasing number of CGTs gain approval and enter the market.

Gene therapies can target any gene in the human genome and transfer modified genetic material to specific cells. It requires editing the cellular genetic code to change specific target cells. A viral vector like adeno-associated virus (AAV) carries genetic instructions to the cell of interest. Non-viral transport vectors can also be employed for the purpose of treating or curing disease. Typically, diseases treated with gene therapy have a single gene or protein aberration responsible for the disorder. Once in, the genetic instructions find the appropriate cells and gene addition, inhibition, correction, reprogramming, and/or cell elimination is induced. These types of gene therapies are common for immune diseases caused by protein production abnormalities, like arthritis, connective tissue disorders, and rare genetic disorders such as sickle cell.

In vivo gene therapy involves direct injection, grafting, or intravenous administration of a vector with therapeutic genetic material into the body. The process can be systemic or localized to a specific cell type or tissue of interest. Ex vivo gene therapy genetically modifies the cells of interest outside of the patient’s body, which is the basis of many cell therapies.

Hundreds of suppliers participate in the market for cell and gene therapies technologies and supplies. While the leading vendors are broad-based companies with offerings in all product categories, most participants provide more niche products. The top suppliers in the market in 2020 were Thermo Fisher, MilliporeSigma, Gibco (Thermo Fisher), and Cytiva (Danaher). The rapid development of the market has driven much innovation of new and existing technologies. This has created opportunities for market participants, and numerous new analytical instrumentation and supply companies have been formed to serve the CGT market.

As development and market entries of CGTs accelerate, the market for suppliers of laboratory and clinical tools within the CGT R&D and manufacturing spaces will see very rapid growth. The Cell & Gene Therapy Technologies and Supplies examines the global market for analytical technologies and products used throughout the various stages of CGT development and manufacturing, evaluating 21 technologies grouped into six categories. The goal of this report is to provide demand growth projections by technique, region, and function, while also providing comprehensive views of the competitive landscape for each technology.

The report can be found at: https://strategic-directions.com/product/2021-cell-gene-therapy-technologies-and-supplies-report/

About Strategic Directions International
Strategic Directions International (SDi), part of Science and Medicine Group, is the leading business intelligence firm in the highly specialized field of analytical and life science instruments. Its client list includes virtually every major analytical instrumentation company in the United States, Europe, and Japan. Founded in 1981, the Los Angeles-based company has published hundreds of market reports and provided proprietary consulting services for a multitude of clients.

Read the full story at https://www.prweb.com/releases/2_billion_dollar_tools_market_for_cell_and_gene_therapy_says_report/prweb17894681.htm.


'/>"/>
Source: PRWeb
Copyright©2021 Vocus, Inc.
All rights reserved


Related biology technology :

1. Peptide Therapeutics Market is Expected to Reach USD 25.4 Billion Globally in 2018: Transparency Market Research
2. Probiotic Action Announces China’s $5 Billion Dollar Investment in Probiotics
3. Medical Gases and Equipment Market is Expected to Reach USD 9 Billion Globally in 2018: Transparency Market Research
4. Protein Engineering Market worth $168 Billion by 2017
5. Pharmacy Automation Systems Market is Expected to Reach USD 7.8 Billion by 2018: Transparency Market Research
6. Biomaterials Market worth $88.4 Billion - 2017
7. Biopsy Devices Market is Expected to Reach USD 2.1 Billion Globally in 2018: Transparency Market Research
8. Global Nuclear Medicine / Radiopharmaceuticals Market worth $5.55 Billion by 2017
9. North American Injectable Drug Delivery Market worth $16.6 Billion by 2017
10. Solution Styrene Butadiene Rubber (S-SBR) Market is Expected to Reach USD 3.2 Billion in 2018: Transparency Market Research
11. North American Nuclear Medicine / Radiopharmaceutical Market Worth $5.55 Billion by 2017
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2021)... ... March 24, 2021 , ... ... Life Sciences and Healthcare firms of all sizes, adds depth to its team ... specialist. Pardillo, who earned his doctorate in computational chemistry from Florida International University ...
(Date:3/27/2021)... ... March 24, 2021 , ... ABI Wellness, ... and reporting approach designed under CEO Mark Watson, today announced a webinar dedicated ... featuring guest speakers Dr. Cameron Clark, Neuropsychologist and Founder of Sharp Thinking, and ...
(Date:3/27/2021)... ... ... The Xtalks editorial team is pleased to announce the launch of the ... joined by editorial team members Ayesha Rashid, Sydney Perelmutter and Mira Nabulsi to discuss ... including insights from industry experts. , The Xtalks Life Science podcast will feature ...
(Date:3/23/2021)... Conn. (PRWEB) , ... March 23, 2021 , ... ... develops solutions for characterizing microbiome populations down to the strain level, recently unveiled ... applications. , Not all microbes are created equal: some are easy to ...
Breaking Biology Technology:
(Date:3/27/2021)... ... March 25, 2021 , ... Phlexglobal announced ... Planet Group, has selected Phlexglobal and its innovative regulatory SaaS software, PhlexSubmission, as ... a comprehensive review of five regulatory software companies, with the review team including ...
(Date:3/27/2021)... ... 25, 2021 , ... The 2021 Virtual Conference on Clinical Trial Supply-Europe ... More and more, clinical trial supply conferences are featuring speakers and forums that ... Asymmetrex’s founder and CEO, James L. Sherley, M.D., Ph.D., presented a talk ...
(Date:3/23/2021)... ... March 23, 2021 , ... G-CON Manufacturing (G-CON), the ... by Matica Biotechnology (Matica Bio), a contract development and manufacturing organization (CDMO) specializing ... the cleanroom build out for its new GMP production facility in College Station, ...
Breaking Biology News(10 mins):